Empagliflozin in Cardiorenal Syndrome Type 1 Clinical Trial
Official title:
The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Effects of Empagliflozin compared with placebo in cardiorenal syndrome type 1, evaluated by MAKE30.
n/a